News and Trends 14 Feb 2023
Minoryx Therapeutics announces X-linked adrenoleukodystrophy data
Minoryx Therapeutics has announced that data from its phase 2/3 ADVANCE clinical trial of lead candidate, leriglitazone, has been published…
biopharma
- Latest Posts
News and Trends 31 Jan 2023
Active Biotech trial confirms eye treatment safety
Active Biotech has announced the completion of the phase I clinical study testing the safety and tolerability of its newly-developed…
News and Trends 11 Jan 2023
Biotech in Asia: looking forward to 2023
Masahiko Hayakawa, head of targeted protein degradation at Astellas Pharma Inc., gives us some insights into the state of the…
News and Trends 23 Dec 2022
Affibody signs €20 million loan agreement
Affibody Medical AB has received a €20 million ($21.2 million) venture debt loan facility from the European Investment Bank, EIB,…
ADVERTISEMENT
News and Trends 13 Dec 2022
Ascletis announces positive COVID-19 trial results
Ascletis Pharma Inc. has announced positive topline results from its phase I multiple ascending dose (MAD) study in healthy subjects…
News and Trends 4 Nov 2022
Centogene launches rare and neurodegenerative disease Biodata Network
German company, Centogene N.V., today (November 4) announced its launch of Biodata Network, a portfolio of data-driven partnering solutions including…
News and Trends 28 Oct 2022
Rila Therapeutics exits stealth mode to address renal fibrosis
Rila Therapeutics, a biotherapeutics company focused on addressing the critical unmet medical needs to treat renal fibrosis, has emerged from…
News and Trends 5 Oct 2022
FDA fast tracks Immutep non-small cell lung cancer candidate
Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti…
News and Trends 5 Oct 2022
OncoSec slashing staff numbers to prioritize pipeline
OncoSec Medical Incorporated is restructuring to prioritize development of its lead clinical candidate TAVO (TAVO-EP). TAVO is a plasmid encoding…
News and Trends 4 Oct 2022
TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies
TrialSpark has announced a new partnership with global pharma company Sanofi to explore novel methods of bringing new treatments to…
ADVERTISEMENT
News and Trends 4 Oct 2022
Spinoff Biohaven launches with $258M and “incredible pipeline”
Biohaven Ltd. launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric…
News and Trends 4 Oct 2022
Patents granted for Poolbeg Pharma influenza and respiratory virus infections treatments
Poolbeg Pharma has been granted patents by the US Patent and Trademark Office (USPTO) for POLB 001, a small molecule…
News and Trends 3 Oct 2022
Oncopeptides starts European commercialization of myeloma drug in Germany
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in Germany. It marks the first…
News and Trends 3 Oct 2022
FDA clears Kira Pharmaceuticals’ phase 2 trial for SLE-TMA treatment
Kira Pharmaceuticals says the US Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for KP104,…
News and Trends 3 Oct 2022
Poxel granted orphan drug designation for kidney disease treatment
French biopharma company Poxel SA says the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to…
News and Trends 3 Oct 2022
Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo
Incyte has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on…
ADVERTISEMENT
News and Trends 30 Sep 2022
Treatment for hot flushes and night sweats accepted for regulatory review by EMA
A treatment for moderate to severe vasomotor symptoms (VMS) has been accepted by the European Medicines Agency (EMA) for regulatory…
News and Trends 26 Sep 2022
Australian Agilex Biolabs expands its capacity with new toxicology testing facility
A toxicology facility with more than 10,000 sq ft of laboratory space has opened in Australia and will help Agilex…
News and Trends 8 Sep 2022
Investment of €130M made by Merck’s MilliporeSigma for life-saving therapies
An investment of €130 million ($130 million) has been invested in Molsheim, France to strengthen manufacturing capabilities for single-use assemblies…
News and Trends 17 Aug 2022
Palisade Bio announces closing of $13.8M upsized underwritten public offering
A biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications has announced today (August 17) the closing of…
